検索結果

ing and marketing approval. The development of SJP-0008 is to be carried out with funding under the program Cyclic Innovation for Clinical Empowerment (CiCLE) established by the Japan Agency for Medic...

ing and marketing approval. The development of SJP-0008 is to be carried out with funding under the program Cyclic Innovation for Clinical Empowerment (CiCLE) established by the Japan Agency for Medic...

Our Initiatives for Society/Environment | About Senju | SENJU Pharmaceutical

ponded Breakdown of Calls Responded Social Contributions We are actively carrying out social action programs with the aim of enhancing our trust relationship with the community. Support for the activi...

Ethical Products for Medical Professionals | Business Activities | About Senju | SENJU Pharmaceutical

lines of medicine. Their clinical data provides us with the invaluable insights that accelerate the progress of our basic research. Working in close cooperation with clinicians, Senju Pharmaceutical h...

研究開発パイプライン | 研究開発活動 | 千寿製薬株式会社

開発進捗状況PROGRESS OF DEVELOPMENT フェーズ1以降の情報を開示しています 開発テーマ対象疾患開発段階（地域） SJP-0132ドライアイ承認（日本） プラノプロフェン抗炎症申請中（ベトナム） SJP-0132ドライアイP3（中国） SJP-0008網膜中心動脈閉塞症P3（日本） SJP-0170緑内障P3（日本） SJP-0154ドライアイP2（日本） SJP-0049アレ...